TrialTrials2016

RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.

Christian Schulz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.